- The biggest health tech stories of 2026 — so farWe’re more than halfway through 2026, and it’s been an eventful year. Here are the five biggest developments we noticed in the first six months. Major AI companies are coming for healthcare.Endpoints · 16d ago↗ source
- STAT+: FDA finalists under reviewThree top contenders to run the FDA are under review by the White HouseSTAT · 16d ago↗ source
- Ipsen succeeds in migraine trials; Tarsus buys iRenix for $75M upfrontPlus news on Alchemab, Scipher and Forte. 💉 Ipsen’s Dysport aces Phase 3 migraine trials: The biotech’s injectable neurotoxin met the primary endpoint of reducing monthly migraine days in two ...Endpoints · 17d ago↗ source